Clinical Trial Update: Efficacy and Safety of TAK-385 in the Treatment of Endometriosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating TAK-385 for endometriosis has completed, with results assessing its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• TAK-385

Snippet

Sponsor: Takeda | Conditions: Endometriosis | Phase 2 | Status: COMPLETED